In addition to leading research into rice bran as a cancer preventive and treatment, the CSU Cancer Center is also providing cutting edge research in other areas of cancer prevention and treatment.

According to the University’s Website, this year more than 500,000 Americans are expected to die of cancer—1,500 people a day. Cancer is the second most common cause of death in the United States, exceeded only by heart disease, accounting for nearly one of every four deaths.

Now, in an unprecedented partnership with Japan, CSU will begin research into a new and promising treatment for cancer—carbon ion therapy, which is currently not available in the United States.

"This partnership gives Colorado State University ready access to study a unique cancer therapy that has shown great promise in Japanese clinical trials. This therapy is not being studied anywhere else in the United States," said Dr. Jac Nickoloff, Head of the Department of Environmental and Radiological Health Sciences. "We want to understand the genetic regulation of tumor responses to carbon ion therapy, including DNA repair pathways and DNA damage-signaling pathways, and how cancer and normal cells respond to this novel therapy."

The relative survival rate for all cancers diagnosed between 1996 and 2004 was 66 percent, up from 50 percent in 1975-1977. The improvement reflects the diagnosis of certain cancers at an earlier stage and improvements in treatment. But cancer survival statistics vary greatly and there are still cancers with extremely low rates of cure, including pancreatic and brain cancers. Carbon ion therapy may offer new hope against these devastating diseases.

For information on more CSU research projects (including the effects of radioactive materials on beef cattle), visit their Web site here.